期刊文献+

Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies 被引量:9

Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies
原文传递
导出
摘要 In this review, we summarize the novel findings from our series of studies on the leading metastasis- related gene, osteopontin (OPN). In our previous gene expression profiling study, OPN was identified as one of the leading genes associated with the metastasis of hepatocellular carcinoma (HCC). We focused on OPN to evaluate its prognostic values and important roles in HCC metastasis. A retrospective study of large cohorts of HCC patients demonstrated that plasma OPN level was one of the leading independent prognostic factors for HCC patients, even in the early stage of HCC, and could serve as a surrogate serologic biomarker for monitoring the treatment response and tumor recurrence after HCC resection. Using both in vitro and in vivo investigations, we found that OPN has an important role in metastasis and tumor growth of HCC and is an attractive potential therapeutic target for combating HCC metastasis. We also found that OPNx HCC cells have much more amplifications at chromosomal regions, and promoter polymorphisms are important in the regulation of OPN expression and tumor growth and lung metastasis of HCC. In this review, we summarize the novel findings from our series of studies on the leading metastasis- related gene, osteopontin (OPN). In our previous gene expression profiling study, OPN was identified as one of the leading genes associated with the metastasis of hepatocellular carcinoma (HCC). We focused on OPN to evaluate its prognostic values and important roles in HCC metastasis. A retrospective study of large cohorts of HCC patients demonstrated that plasma OPN level was one of the leading independent prognostic factors for HCC patients, even in the early stage of HCC, and could serve as a surrogate serologic biomarker for monitoring the treatment response and tumor recurrence after HCC resection. Using both in vitro and in vivo investigations, we found that OPN has an important role in metastasis and tumor growth of HCC and is an attractive potential therapeutic target for combating HCC metastasis. We also found that OPNx HCC cells have much more amplifications at chromosomal regions, and promoter polymorphisms are important in the regulation of OPN expression and tumor growth and lung metastasis of HCC.
作者 Lunxiu Qin
机构地区 Department of Surgery
出处 《Frontiers of Medicine》 SCIE CAS CSCD 2014年第1期24-32,共9页 医学前沿(英文版)
关键词 osteopontin (OPN) hepatocellular carcinoma METASTASIS prognosis therapeutic target BIOMARKER geneticpolymorphism osteopontin (OPN) hepatocellular carcinoma metastasis prognosis therapeutic target biomarker geneticpolymorphism
  • 相关文献

同被引文献35

引证文献9

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部